In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Corium International Inc. (NASDAQ:CORI) reported that Perceptive Advisors has picked up 3,847,133 of common stock as of 2017-05-23.
The acquisition brings the aggregate amount owned by Perceptive Advisors to a total of 3,847,133 representing less than 13.16% stake in the company.
For those not familiar with the company, Corium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products. As of September 30, 2016, the Company had multiple programs in preclinical and clinical development focused primarily on the treatment of neurological disorders, with two lead programs in Alzheimer’s disease. The Company has two transdermal platforms: Corplex for small molecules and MicroCor, a biodegradable microstructure technology for small molecules and biologics, including vaccines, peptides and proteins. Its late-stage pipeline includes a contraceptive patch, which has completed Phase III trials, and additional transdermal products that are being developed with other partners. Its products include Clonidine TDS, Fentanyl TDS and Crest Whitestrips. Its pipeline products include Twirla, Corplex Donepezil and Corplex Memantine, Donepezil, Corplex Ropinerole, MicroCor hPTH(1-34) and Motion Sickness Patch.
A glance at Corium International Inc. (NASDAQ:CORI)’s key stats reveals a current market capitalization of 178.34 Million based on 29.23 Million shares outstanding and a price at last close of $6.39 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-19, Bjerkholt picked up 6,341 at a purchase price of $3.70. This brings their total holding to 12,000 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Corium International Inc. (NASDAQ:CORI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.